Obtaining Novel Endpoint Reliability and Acceptance Expert Meeting

JULY 27, 2021 TO JULY 28, 2021

CTTI Project: Developing Novel Endpoints

Meeting Objectives:

Identify the barriers and discuss solutions to the adoption of DHT-derived endpoints into pivotal trials
Discuss the data needed to prove that a DHT-derived endpoint is ready for a pivotal trial
Explore how collaboration and other new efforts can advance the adoption of DHT-derived endpoints

Meeting Location:

Virtual Meeting

Meeting Agenda

Meeting Summary

List of meeting attendees

Pre-Meeting Materials

Full Presentation Set - Day 1

Full Presentation Set - Day 2

Meeting Materials:

Day 1

Session I: DHT-Derived Novel Endpoint Development: Current Landscape
Session II: DHT-Derived Endpoints in Trials: The Reality vs. the Idea
Mentimeter Results - Day 1

Day 2

Session III: Ensuring a DHT-Derived Endpoint is Pivotal Trial Ready
Session IV: Advancing Adoption through Collaboration
- Leveraging Evidence Presentation
- Open Source for Digital Endpoints: Open Wearables Initiative
Mentimeter Results - Day 2

The views and opinions expressed in these presentations are those of the individual presenter and should not be attributed to the Clinical Trials Transformation Initiative, or any organization with which the presenter is employed or affiliated.